Device Desk

Private service · Not FDA

FDA device establishment · Carpinteria, CA

This page shows the yearly renewal for this site, from FDA’s public record.

Device Desk is a private service. We are not FDA. We never file or pay for you.

Renewal dossierDD-2022180As of September 30, 2026

Agilent Technologies, Inc.

Registration 2022180FEI 2022180CARPINTERIA, CA

Owner/operator: Agilent Technologies, Inc

  • Develop Specifications But Do Not Manufacture At This Facility
  • Manufacture Medical Device
  • Manufacture Medical Device for Another Party (Contract Manufacturer)
  • Repack or Relabel Medical Device

Renewal due by December 31, 2026

Registered through 2026. Renew between October 1 and December 31, 2026, to stay registered for 2027.

90days left in the window

The 2026 window

  1. Oct 1Window opens91 days left
  2. Nov 3Where you stand58 days left
  3. Dec 1Our pay-by date30 days left
  4. Dec 15Two weeks left16 days left
  5. Dec 23Holiday week8 days left
  6. Dec 29Two days left2 days left
  7. Dec 31Window closes0 days left
an email on that date our pay-by date to December 31
FDA fee, FY2027
$13,785
Our pay-by suggestion
Dec 1
Listed devices
39
Added, last 12 months
0

FDA sets who pays the fee and who may qualify for a waiver; its fee page says so. The fee is paid only on FDA’s own fee site. Never through us. FDA’s fee page

The steps, in order

  1. Pay FDA's annual feeYou

    Order and pay the FY2027 establishment fee on FDA's Device Facility User Fee site. FDA emails you a PIN when you order.

    FDA: registration and listing payment process

  2. Wait for the payment confirmation numberYou

    FDA emails a Payment Confirmation Number (PCN) once the payment processes, which FDA says typically takes several days. That is why we suggest paying by December 1.

    FDA: registration and listing payment process

  3. Renew the registration in FDA's systemYou

    Sign in to FDA's Unified Registration and Listing System (FURLS), complete the annual registration and apply your PIN and PCN. FDA does not count the registration as complete until both are applied.

    FDA: device registration and listing

  4. Review every listingYou

    In the same window, review each listing on file and report any changes, deletions and new listings. Your Listing Review Sheet puts every listing on one page.

    FDA: device registration and listing

Every listed device 39

CodeDeviceClassRegulationPremarket
QQTKi-67 IHC MIB-1 pharmDx (Dako Omnis)Immunohistochemistry Assay, Antibody, Ki-67Class 3—P210026
SBLMAGE-A4 IHC 1F9 pharmDxImmunohistochemistry Assay, Antibody, Melanoma-Associated Antigen A4Class 321 CFR 864.1860P230016
PLSPD-L1 IHC 22C3 pharmDxImmunohistochemistry Assay, Antibody, Programmed Death-Ligand 1Class 3—P150013
PLSPD-L1 IHC 28-8 pharmDxImmunohistochemistry Assay, Antibody, Programmed Death-Ligand 1Class 3—P150025
QNHMLH1 IHC pharmDx (Dako Omnis)Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein AssayClass 321 CFR 864.1860P250004
MYAFLEX Monoclonal Rabbit Anti-Human Estrogen Receptor ?, Clone EP1 Ready-to-Use (Dako Omnis)Immunohistochemistry Antibody Assay, Estrogen ReceptorClass 221 CFR 864.1860K170028
MYAMonoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 1294Immunohistochemistry Antibody Assay, Estrogen ReceptorClass 221 CFR 864.1860K042884
MYAFLEX Monoclonal Rabbit Anti-Human Estrogen Receptor ?, Clone EP1, Ready-to-Use (Link)Immunohistochemistry Antibody Assay, Estrogen ReceptorClass 221 CFR 864.1860K120663
MXZMonoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 636Immunohistochemistry Assay, Antibody, Progesterone ReceptorClass 221 CFR 864.1860K020023
MXZFLEX Monoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 636, Ready-to-Use (Link)Immunohistochemistry Assay, Antibody, Progesterone ReceptorClass 221 CFR 864.1860K130861
MXZMonoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 1294Immunohistochemistry Assay, Antibody, Progesterone ReceptorClass 221 CFR 864.1860K042884
MXZFLEX Monoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 1294, Ready-to-Use (Dako Omnis)Immunohistochemistry Assay, Antibody, Progesterone ReceptorClass 221 CFR 864.1860K170005

and 27 more on your full dossier

What changed

Nothing added in the last twelve months, and no change seen on the record yet.

Data provided by the U.S. Food and Drug Administration (https://open.fda.gov). FDA does not endorse Device Desk.FDA’s own record is always the authority.

How we got this date

  1. FDA asks every device site to renew its registration each year.
  2. The renewal window runs from October 1, 2026 to December 31, 2026.
  3. A renewal in this window covers 2027.
  4. The rule is 21 CFR 807.22(b).

FDA’s record shows this registration runs through 2026.

We read this from FDA’s public record on September 30, 2026.

Read FDA’s page on registration

Watch for mail that looks like it is from FDA and asks you to pay a company. You pay FDA’s fee only in FDA’s own system.

Keep this desk: $249 a year

We keep this page current each week. We email you before each date in the window, and when FDA’s record shows you renewed.

Already a member? Sign in

Renews each year until you cancel. Cancel any time from your account.

Is this right?

We copy this from FDA’s public record. FDA’s own record always wins. A listing missing here does not prove anything about FDA’s record.

More device sites in California